Covid-recovered at 3-5 times more Omicron reinfection risk: WHO

Individuals who have recovered from Covid-19 are 3 to 5 times more likely to be reinfected with the Omicron variant compared to Delta, according to the World Health Organization (WHO)

Omicron, Covid,
IANS New Delhi
2 min read Last Updated : Jan 08 2022 | 12:47 PM IST

Individuals who have recovered from Covid-19 are 3 to 5 times more likely to be reinfected with the Omicron variant compared to Delta, according to the World Health Organization (WHO).

According to Hans Henri P Kluge, the WHO's Regional Director for Europe, Omicron variant can evade previous immunity in people.

"So it can still infect those who have had Covid-19 in the past, those who are unvaccinated, and those who were vaccinated many months ago," Kluge said in a recent note.

"There are three things that we need to do urgently: protect ourselves through vaccination, prevent further infections, and prepare health systems for a surge in cases".

Kluge said that health authorities must strengthen capacity, increase testing and trace capacities, engage primary health care in case management, prepare hospitals for a surge, and support health and frontline workers.

"Two years in, our health workers are being severely tested once again. It is deeply worrying that one in 5 is suffering from anxiety and depression from the pandemic. Their concerns must be addressed and their need for manageable working conditions supported," the WHO executive had stressed.

Europe witnessed Covid cases cross 1 million for the first time this week. Europe has recorded over 100 million Covid cases, more than a third of all infections worldwide, since the start of the pandemic.

Meanwhile, India witnessed a 21 per cent surge in 24 hours, as it recorded more than 1.4 lakh fresh Covid infections on Friday.

With the addition of 285 new deaths, the total deaths toll has climbed to 4,83,463.

The Omicron infection tally reached 3,071 across the nation, according to the Health Ministry.

--IANS

na/ksk/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronCoronavirus TestsCoronavirus Vaccine

First Published: Jan 08 2022 | 12:47 PM IST

Next Story